{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-22-002532","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.497722+00:00","generated_at":"2026-06-23T23:53:30.749497+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"vTv Therapeutics appoints Dr. Jonathan Isaacsohn as Chair of the Board","bullets":["Dr. Jonathan Isaacsohn appointed as member and Chair of Board effective August 9, 2022.","He is President and CEO of CinRx Pharma, LLC; appointment per July 22, 2022 stock purchase agreement.","Annual cash compensation of $70,000 plus annual equity grant of 50,000 options; initial grant of 50,000 options on appointment.","Dr. Isaacsohn has over 25 years in drug development; served as CMO of Teva Pharmaceutical Industries."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-22-002532","json":"https://secwatch.observer/filing/0000950142-22-002532.json","markdown":"https://secwatch.observer/filing/0000950142-22-002532.md","text":"https://secwatch.observer/filing/0000950142-22-002532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002532/0000950142-22-002532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002532/eh220279180_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:53:30.749497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ea59eea12","claim":"Dr. Jonathan Isaacsohn was appointed as Chair of the Board at vTv Therapeutics Inc..","evidence_excerpt":"appointed Dr. Jonathan Isaacsohn as a member and chair of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002532/0000950142-22-002532-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}